confirmed these findings, illustrating a proportional increase in ARD1 levels from low‐grade atypical hyperplasia to hepatocellular carcinoma and establishing a correlation between ARD1 expression and hepatocellular carcinoma progression [9]. The gene discussed is NAA10; the disease is hepatocellular carcinoma.